Retail & Wholesale » Retail | New Ray Medicine International Holding Ltd.

New Ray Medicine International Holding Ltd. | Balance Sheet

Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
93,409.00
150,942.00
56,795.00
71,599.00
90,195.00
146,101
Total Accounts Receivable
64,366.00
61,972.00
65,714.00
52,168.00
69,176.00
84,407
Inventories
36,813.00
79,245.00
117,340.00
136,882.00
214,651.00
158,068
Other Current Assets
22,875.00
2,135.00
5,185.00
4,817.00
85,760.00
6,361
Total Current Assets
217,463.00
294,294.00
245,034.00
265,466.00
459,782.00
394,937
Net Property, Plant & Equipment
7,051.00
7,718.00
9,434.00
11,860.00
10,712.00
16,148
Total Investments and Advances
-
18,723.00
200,993.00
193,184.00
297,413.00
303,344
Intangible Assets
-
-
18,308.00
15,353.00
14,515.00
12,022
Other Assets
9,373.00
8,999.00
42,803.00
48,873.00
47,962.00
41,621
Total Assets
233,887.00
329,734.00
516,572.00
534,736.00
830,384.00
768,072
ST Debt & Current Portion LT Debt
-
-
-
16,769.00
-
Accounts Payable
2,301.00
8,579.00
18,206.00
25,671.00
82,054.00
Income Tax Payable
13,268.00
9,860.00
6,561.00
2,193.00
1,121.00
Other Current Liabilities
1,823.00
3,120.00
7,424.00
11,294.00
10,655.00
Total Current Liabilities
17,392.00
21,559.00
32,191.00
55,927.00
93,830.00
Deferred Taxes
3,297.00
4,984.00
6,718.00
7,122.00
9,729.00
Total Liabilities
20,689.00
26,543.00
38,909.00
63,049.00
103,559.00
Common Equity (Total)
213,198.00
303,191.00
477,663.00
471,687.00
726,825.00
Total Shareholders' Equity
213,198.00
303,191.00
477,663.00
471,687.00
726,825.00
Total Equity
213,198.00
303,191.00
477,663.00
471,687.00
726,825.00
Liabilities & Shareholders' Equity
233,887.00
329,734.00
516,572.00
534,736.00
830,384.00

About New Ray Medicine International Holding

View Profile
Address
B-C, 37th Floor
Hangzhou Zhejiang 311112
China
Employees -
Website http://www.newraymedicine.com
Updated 07/08/2019
New Ray Medicine International Holding Ltd. is an investment company, which engages in the distribution and trading of pharmaceutical products. It operates through the following business segments: Injection Drugs; Capsule and Granule Drugs; Tablet Drugs; Marketing and Promotion Services; and Others. The Injection Drugs segment includes the trading of injection drugs.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.